메뉴 건너뛰기




Volumn 15, Issue 1, 1999, Pages 83-96

Dose independent pharmacokinetics of caffeine after intravenous administration under a chronic food-limited regimen

Author keywords

Caffeine; Cytochrome P450; Dimethylxanthine metabolites; Pharmacokinetics

Indexed keywords

CAFFEINE; DRUG METABOLITE; METHYLXANTHINE DERIVATIVE; PARAXANTHINE; THEOBROMINE; THEOPHYLLINE;

EID: 0033056933     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI.1999.15.1.83     Document Type: Review
Times cited : (5)

References (20)
  • 1
    • 0002430991 scopus 로고
    • Caffeine as a drug of abuse
    • Gibbon RJ, Israel Y, Kalant M, Poplan RE, Schmidt W, Smart RG, eds New York: John Wiley & Sons
    • Gilbert RM. Caffeine as a drug of abuse. In. Gibbon RJ, Israel Y, Kalant M, Poplan RE, Schmidt W, Smart RG, eds Research Advances in Alcohol and Drug Problems. Vol. 3, New York: John Wiley & Sons, 1976; 49-176.
    • (1976) Research Advances in Alcohol and Drug Problems , vol.3 , pp. 49-176
    • Gilbert, R.M.1
  • 2
    • 0023792657 scopus 로고
    • Measurement of coffee and caffeine intake: Implications for epidemiological research
    • Schreiber GB, Maffeo CE, Robins M, et al. Measurement of coffee and caffeine intake: implications for epidemiological research. Prev Med 1988; 17: 280-294.
    • (1988) Prev Med , vol.17 , pp. 280-294
    • Schreiber, G.B.1    Maffeo, C.E.2    Robins, M.3
  • 3
    • 0026730694 scopus 로고
    • Caffeine and the central nervous system: Mechanisms of action, biochemical, metabolic and psychostimulant effects
    • Nehlig A, Daval J-L, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev 1992; 17: 139-170.
    • (1992) Brain Res Rev , vol.17 , pp. 139-170
    • Nehlig, A.1    Daval, J.-L.2    Debry, G.3
  • 4
    • 0023841493 scopus 로고
    • Caffeine physical dependence: A review of human and laboratory studies
    • Griffiths RR, Woodson PP, Caffeine physical dependence: a review of human and laboratory studies. Psychopharmacology 1988; 94: 437-451.
    • (1988) Psychopharmacology , vol.94 , pp. 437-451
    • Griffiths, R.R.1    Woodson, P.P.2
  • 5
    • 0023839975 scopus 로고
    • Effect of behavior state on caffeine's ability to alter blood pressure
    • Pincomb GA, Lovallo WR, Passey RB, Wilson MF. Effect of behavior state on caffeine's ability to alter blood pressure. Am J Cardiol 1988; 61: 798-802.
    • (1988) Am J Cardiol , vol.61 , pp. 798-802
    • Pincomb, G.A.1    Lovallo, W.R.2    Passey, R.B.3    Wilson, M.F.4
  • 7
    • 0028241592 scopus 로고
    • Caffeine metabolism by human hepatic cytochromes P450: Contributions of 1A2, 2E1 and 3A isoforms
    • Tassaneeyakul W, Birkett DJ, McManus ME, et al. Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms. Biochem Pharmacol 1994; 47: 1767-1776.
    • (1994) Biochem Pharmacol , vol.47 , pp. 1767-1776
    • Tassaneeyakul, W.1    Birkett, D.J.2    McManus, M.E.3
  • 8
    • 0001932043 scopus 로고
    • Interspecies composition of caffeine disposition
    • Dews PB, ed. New York: Springer-Verlag
    • Bonati M, Gaxattini S. Interspecies composition of caffeine disposition. In: Dews PB, ed. Caffeine. New York: Springer-Verlag, 1984: 48-56.
    • (1984) Caffeine , pp. 48-56
    • Bonati, M.1    Gaxattini, S.2
  • 14
    • 0028821336 scopus 로고
    • Oral and IP caffeine pharmacokinetics under a chronic food-limitation condition
    • Lau CE, Ma F, Falk JL. Oral and IP caffeine pharmacokinetics under a chronic food-limitation condition. Pharmacol Biochem Behav 1995; 50: 245-252.
    • (1995) Pharmacol Biochem Behav , vol.50 , pp. 245-252
    • Lau, C.E.1    Ma, F.2    Falk, J.L.3
  • 15
    • 0029898197 scopus 로고    scopus 로고
    • Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: Relating DRL performance to pharmacokinetics
    • Lau CE, Ma F, Wang Y, Smith C. Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics. Psychopharmacology 1996; 126: 241-248.
    • (1996) Psychopharmacology , vol.126 , pp. 241-248
    • Lau, C.E.1    Ma, F.2    Wang, Y.3    Smith, C.4
  • 16
    • 0026355830 scopus 로고
    • Sustained synergism by chronic caffeine of the motor control deficit produced by midazolam
    • Lau CE, Falk JL. Sustained synergism by chronic caffeine of the motor control deficit produced by midazolam. Pharmacol Biochem Behav 1991; 40: 723-731.
    • (1991) Pharmacol Biochem Behav , vol.40 , pp. 723-731
    • Lau, C.E.1    Falk, J.L.2
  • 17
    • 0027939243 scopus 로고
    • The effects of nutrition on chemical toxicity
    • Parke D, Ioannides C. The effects of nutrition on chemical toxicity. Drug Metab Rev 1994; 26: 739-765.
    • (1994) Drug Metab Rev , vol.26 , pp. 739-765
    • Parke, D.1    Ioannides, C.2
  • 18
    • 0024562865 scopus 로고
    • Effects of aging and caloric restriction on hepatic drug metabolizing enzymes in the Fischer 344 rat. I: The cytochrome P-450 dependent monooxygenase system
    • Leakey JA, Cunny HC, Bazare J, et al. Effects of aging and caloric restriction on hepatic drug metabolizing enzymes in the Fischer 344 rat. I: The cytochrome P-450 dependent monooxygenase system. Mech Ageing Dev 1989; 48: 145-155.
    • (1989) Mech Ageing Dev , vol.48 , pp. 145-155
    • Leakey, J.A.1    Cunny, H.C.2    Bazare, J.3
  • 20
    • 0020024489 scopus 로고
    • Modulation of drug metabolism by food restriction in male rats
    • Sachan DS. Modulation of drug metabolism by food restriction in male rats. Biochem Biophys Res Comm 1982; 104: 984-989.
    • (1982) Biochem Biophys Res Comm , vol.104 , pp. 984-989
    • Sachan, D.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.